340-OR: Outcomes of a Digital Diabetes Self-Management Support Program Stratified by A1C

Abstract

Background: Diabetes Self-Management Support (DSMS) programs are designed to assist people with diabetes as they implement and sustain the behaviors needed to manage their disease. In-person DSMS programs have many attendance barriers that can be mitigated through digital delivery. This study looks at results from the only ADA recognized online digital DSMS program (as of Jan 2020). The program collects diverse Patient Reported Outcomes (PROs) to track patient progress and program impact. This analysis presents digital DSMS program outcomes, focusing on individuals with an A1c >9%, for whom health risk is markedly increased. Methods: A retrospective analysis of individuals enrolled in a 12-week digital DSMS program evaluated changes from baseline to program completion. Changes in anxiety, depression, financial toxicity, overall physical and mental health, medication adherence, stress, diabetes distress, body mass index, and A1c were evaluated for cohorts delineated by baseline A1c values. Descriptive statistics define frequency and data collected from validated PROs were analyzed to evaluate the outcomes of the digital DSMS program. Results: To date, 1,349 people with diabetes have participated in the digital DSMS program. Of these, 843 completed and provided both baseline and 3-month outcome measures. Across all A1c categories, there were significant improvements in physical health, medication adherence, stress, and BMI (p < 0.05). Elevated A1c categories (A1c ≥ 7%) all showed decreased A1c values at month 3 compared to enrollment (p < 0.01), people with higher baseline A1c values saw the greatest decrease, A1c ≥ 10% decreased 4.17% (pre:11.32 - post: 7.15%), A1c 9-9.9% decreased 1.34% (pre: 9.29 - post: 7.95%). Conclusions: Outcomes suggest that a digital DSMS program can improve glycemic control, as previously reported, but also PROs, and that a digital delivery of a DSMS program is an effective intervention, particularly for individuals with elevated A1c for whom health risks are elevated. Disclosure J. Patterson: None. M. Allison: Employee; Self; Pack Health. K.J. Brassil: None. S.B. Burton: None. T.T. Norbu: None. M. Rasulnia: None. D. Patel: None.